The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy

Cell death regulation is vital for maintenance of homeostasis and proper development of multicellular organisms. Inhibitor of apoptosis (IAP) proteins are implicated in multiple ways in cell death regulation, ranging from inhibition of apoptosis and necrosis to the regulation of cell cycle and infla...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental Oncology
Datum:2012
Hauptverfasser: de Almagro, M.C., Vucic, D.
Format: Artikel
Sprache:Englisch
Veröffentlicht: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2012
Schlagworte:
Online Zugang:https://nasplib.isofts.kiev.ua/handle/123456789/139069
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy / M.C. de Almagro, D. Vucic // Experimental Oncology. — 2012. — Т. 34, № 3. — С. 200-211. — Бібліогр.: 138 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
_version_ 1862622951451394048
author de Almagro, M.C.
Vucic, D.
author_facet de Almagro, M.C.
Vucic, D.
citation_txt The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy / M.C. de Almagro, D. Vucic // Experimental Oncology. — 2012. — Т. 34, № 3. — С. 200-211. — Бібліогр.: 138 назв. — англ.
collection DSpace DC
container_title Experimental Oncology
description Cell death regulation is vital for maintenance of homeostasis and proper development of multicellular organisms. Inhibitor of apoptosis (IAP) proteins are implicated in multiple ways in cell death regulation, ranging from inhibition of apoptosis and necrosis to the regulation of cell cycle and inflammation. Due to their prominent ability to control cell death and elevated expression in a variety of cancer cell types, IAP proteins are attractive targets for the development of novel anti-cancer treatments. The most widely used strategy for targeting IAP proteins is based on mimicking the natural IAP antagonist, SMAC/DIABLO. IAP antagonists are currently being tested in humans and they were designed for anti-cancer therapy but they could potentially also be considered for treatments of the immune system disorders. In this manuscript we will review the functional roles of IAP proteins, specifically of c-IAP1, c-IAP2, ML-IAP and XIAP, and evaluate IAP targeting strategies for disease treatments. This article is part of a Special Issue entitled “Apoptosis: Four Decades Later”.
first_indexed 2025-11-30T02:56:35Z
format Article
fulltext
id nasplib_isofts_kiev_ua-123456789-139069
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
issn 1812-9269
language English
last_indexed 2025-11-30T02:56:35Z
publishDate 2012
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
record_format dspace
spelling de Almagro, M.C.
Vucic, D.
2018-06-19T18:57:47Z
2018-06-19T18:57:47Z
2012
The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy / M.C. de Almagro, D. Vucic // Experimental Oncology. — 2012. — Т. 34, № 3. — С. 200-211. — Бібліогр.: 138 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/139069
Cell death regulation is vital for maintenance of homeostasis and proper development of multicellular organisms. Inhibitor of apoptosis (IAP) proteins are implicated in multiple ways in cell death regulation, ranging from inhibition of apoptosis and necrosis to the regulation of cell cycle and inflammation. Due to their prominent ability to control cell death and elevated expression in a variety of cancer cell types, IAP proteins are attractive targets for the development of novel anti-cancer treatments. The most widely used strategy for targeting IAP proteins is based on mimicking the natural IAP antagonist, SMAC/DIABLO. IAP antagonists are currently being tested in humans and they were designed for anti-cancer therapy but they could potentially also be considered for treatments of the immune system disorders. In this manuscript we will review the functional roles of IAP proteins, specifically of c-IAP1, c-IAP2, ML-IAP and XIAP, and evaluate IAP targeting strategies for disease treatments. This article is part of a Special Issue entitled “Apoptosis: Four Decades Later”.
The authors thank Wayne Fairbrother and Eugene
 Varfolomeev for critical reading of the manuscript.
 Both authors are employees of Genentech, Inc.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Invited review
The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy
Article
published earlier
spellingShingle The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy
de Almagro, M.C.
Vucic, D.
Invited review
title The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy
title_full The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy
title_fullStr The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy
title_full_unstemmed The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy
title_short The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy
title_sort inhibitor of apoptosis (iap) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy
topic Invited review
topic_facet Invited review
url https://nasplib.isofts.kiev.ua/handle/123456789/139069
work_keys_str_mv AT dealmagromc theinhibitorofapoptosisiapproteinsarecriticalregulatorsofsignalingpathwaysandtargetsforanticancertherapy
AT vucicd theinhibitorofapoptosisiapproteinsarecriticalregulatorsofsignalingpathwaysandtargetsforanticancertherapy
AT dealmagromc inhibitorofapoptosisiapproteinsarecriticalregulatorsofsignalingpathwaysandtargetsforanticancertherapy
AT vucicd inhibitorofapoptosisiapproteinsarecriticalregulatorsofsignalingpathwaysandtargetsforanticancertherapy